| TOP PICK | | OSI Pharmaceuticals Inc. | OSIP-Q | 53.710 | Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year. | 2004-08-13 | |
| TOP PICK | | Amgen Inc. | AMGN-Q | 54.360 | A very rapidly growing company. Earnings per share growth is in excess of 20% yearly. PE ratio barely more than that. | 2004-08-13 | |
| TOP PICK | | Eli Lilly & Co. | LLY-N | 61.570 | Lots of new products. Rapid profit growth. | 2004-08-13 | |
| TOP PICK | | Novartis AG | NVS-N | 45.760 | Growing very well. Their biggest drug is for high blood pressure but also have a good product line for cancer treatment. Not many patent exposures in the near-term. | 2004-08-13 | |
Rss Top Picks Feed